Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brucker

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trialM Hebbar, B Chibaudel, T André, et al.
Cell Death Discovery|March 26, 2026
Tumor-associated epilepsy and high expression of xCT shape the proteome of IDH-wildtype glioblastomaIris Divé, Jasmin A Schäfer, Katharina J Weber, et al.
European Journal of Epidemiology|April 5, 2023
Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication PlatformDaniel Maier, Jörg Janne Vehreschild, Barbara Uhl, et al.
Scientific Data|March 13, 2026
A comprehensive European Colorectal Cancer Cohort datasetPetr Holub, Outi Törnwall, Eva Garcia Alvarez, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trialM Hebbar, B Chibaudel, T André, et al.
Cell Death Discovery|March 26, 2026
Tumor-associated epilepsy and high expression of xCT shape the proteome of IDH-wildtype glioblastomaIris Divé, Jasmin A Schäfer, Katharina J Weber, et al.
European Journal of Epidemiology|April 5, 2023
Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication PlatformDaniel Maier, Jörg Janne Vehreschild, Barbara Uhl, et al.
Scientific Data|March 13, 2026
A comprehensive European Colorectal Cancer Cohort datasetPetr Holub, Outi Törnwall, Eva Garcia Alvarez, et al.
Pageof 4